Navigation Links
EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
Date:9/12/2007

OAK BROOK, Ill., Sept. 12 /PRNewswire/ -- EPI-Q, a leading healthcare management consulting firm, announces today the opening of their East coast office and a key appointment. EPI-Q, Inc. specializes in assisting life sciences firms and healthcare providers enhance both the clinical outcomes and cost-effectiveness of patient care.

Andrew Baker joins EPI-Q as Vice President-Business Development, based in Harrison, NY. Mr. Baker will have responsibility for global business development and marketing.

Mr. Baker has over 20 years' experience operating in and consulting to the global biopharmaceutical and healthcare industries. He has led initiatives in the areas of commercial opportunity assessment, product development, lifecycle management, strategic planning, and global pricing and reimbursement.

Prior to joining EPI-Q, Mr. Baker spent 14 years with Pfizer and was a founding member of the company's Outcomes Research function. While at Pfizer, Mr. Baker led the development of the Practical Outcomes Researcher(R) online quality improvement program to assist healthcare organizations conduct quality measurement and improvement initiatives within major therapeutic areas. The program won the American College of Medical Quality's Institutional Achievement Award. He also was with Merck's public policy group and pioneered the establishment of Arthur D. Little's health economics consulting practice.

Mark Jewell, Ph.D., President of EPI-Q, commented, "Drew's experience and success in the global pharmaceutical industry will enhance EPI-Q's capabilities and broaden our service offerings both to our life sciences industry clients and our healthcare provider and payer clients. The opening of our East coast office will improve our ability to serve our growing client base in this area. Furthermore, Drew's insight and expertise will contribute to forming and executing our strategic goal to grow the business both in the US and major global markets."

M
'/>"/>

SOURCE EPI-Q, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. First global SARS meet opens
2. Cancer Drug Opens Arteries
3. Ranbaxy opens Drug discovery centre in Gurgaon
4. Delhi Hospital Opens Up Avenues For Computer-Aided Knee Replacement
5. Cancer Hospice Opens New In-patient Unit
6. Center for Celiac Disease Opens
7. Review Opens Bag of Tricks for Reducing Pain from Children’s Shot
8. Apollo Eyes Expansion in Kolkata, Opens Ayurveda Clinic
9. Largest Ever African HIV Vaccine Trial Opens in South Africa
10. Apollo Opens Blood Cancer Clinic in Kolkata
11. China Opens Doors For Foreign Investments In Hospitals Care System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...partment of Defense and Federal Agencies in, the ...olden Phoenix is a, four-day, multi-agency colla...l, state and local agencies with large and complex...ding a vital, ad-hoc, secure mobile communicatio...ise., NORFOLK, Va., July 25 /PRNewswire/ -- Datal...
(Date:7/25/2008).../ -- The Elekta Family of Companies will,showcase ... the 2008,American Association of Physicists in Me...e joint forces of Elekta, IMPAC and CMS are delive...elivery solutions that,streamline the treatment pr...as well as enhance clinician efficiency., "Our re...
(Date:7/25/2008)...ogram delivers immediate cost savings for http://...ss to language interpreters] to firms switching l...s. , Washington, D.C. (V...e-inc.com/index.html [(Language Learning Enterpri... translation, and language instruction services to...
(Date:7/25/2008)...us-based law firm represents Pickerington man who ...olumbus-area Kroger store , ...http://www.donaheyohioinjurylawyers.com [The Dona...law firms in central Ohio, has filed a product lia...08CV9804) against The Kroger Co., in connection wi...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2
...ldren can be treated effectively with a single dos...ajor global health problem particularly in // chil...resource-limited countries where cholera occurs, a...tant as it reduces the demands on the healthcare s...
... effective in prevent the brain damages similar to...th Florida have found that a component of green te...ns of mice genetically programmed to develop the n... component, called epigallocatechin-3-gallate (EGC...
...t smoking is injurious to health. The maximum harm...cts of smoking may be understood by the effect it ...xidase A (MAOA) is important in mood regulation an... regulate blood pressure. In a new study, research...
...hange the curriculum for medicine by integrating m...ment it within two years. "Today's medical curric...ation of both the modern and traditional practices... to come out within two years time," said health m...
Other Medicine News:
(Date:7/24/2008)...gned to take body temperature, for home,and clinic...ll/ --- Kidz-Med, Inc.,(subsidiary of American Sci...States distributor of the Thermofocus(R) 5-in-1 no...results of a clinical study,conducted by the Secon...,Milan, Italy, which proves that the Thermofocus(R...
(Date:7/23/2008)...-- Sound Pharmaceuticals (SPI) has filed,an Invest...e clinical,testing of a proprietary formulation of...d hearing loss or ototoxicity. The oral capsule,co...nced stage lung cancer,and head and neck cancer pa... marks the second development program for SPI to e...
(Date:7/23/2008)...irstCall/ -- Dendreon Corporation,(Nasdaq: DNDN )...ata,Monitoring Committee (IDMC) to review in Octob...elating to the Company,s Phase 3 IMPACT (IMmunothe...nown as D9902B) clinical trial,of PROVENGE(R) (sip...nal,active cellular immunotherapy for the treatmen...
(Date:7/22/2008)...cs Development Initiative bring MJFF,s,current act...anuary 20,2009, NEW YORK, July 22 /PRNewswire-US...ery of transformative treatments and a cure for Pa...or Parkinson,s Research has awarded,$2.7 million i...e awards,were granted under MJFF,s Therapeutics De...
Breaking Medicine Technology:Pediatric Study Finds 21st Century Non-Contact Thermometer as Accurate as Conventional Thermometers 2Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3Grubb 26 Ellis Healthcare REIT Acquires Park Place Office Park in Dayton Ohio 8925 1Grubb 26 Ellis Healthcare REIT Acquires Park Place Office Park in Dayton Ohio 8925 2Grubb 26 Ellis Healthcare REIT Acquires Park Place Office Park in Dayton Ohio 8925 3DNC 3A Rudy Shows Again Hes Out of Touch With Americas Priorities 8922 1DNC 3A Rudy Shows Again Hes Out of Touch With Americas Priorities 8922 2DNC 3A Rudy Shows Again Hes Out of Touch With Americas Priorities 8922 3Risk of HIV West Nile Virus E Coli Transmission May be Reduced Through Improved Blood Screening Methods 8918 1Risk of HIV West Nile Virus E Coli Transmission May be Reduced Through Improved Blood Screening Methods 8918 2Holiday Travel Bad Eating Habits a Recipe for Stomach Trouble 8916 1Holiday Travel Bad Eating Habits a Recipe for Stomach Trouble 8916 2
...RIDGE, Mass.--(BUSINESS WIRE)--Jun 14, 2007 - Comb...ed the presentation of,additional data related to ...2 and CRx-139, at the European League Against,Rheu...ting, June,13-16, 2007 in Barcelona, Spain., CRx-1...e and Chondrocyte,Inflammatory Mediators by CRx-10...
...FORD, Conn.--(BUSINESS WIRE)--Jun 13, 2007 - Neuro...t data from previous,Phase 1 and Phase 2a clinical...or the treatment of insomnia, were presented in tw... Associated,Professional Sleep Societies (APSS) in...dies with NG2-73 in chronic insomnia patients,are ...
Other Medicine Technology:Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 2Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 3Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 4Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 2Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 3Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 4Neurogen Proprietary Insomnia Compound Data for Two Studies,Presented at Associated Professional Sleep Societies Annual Meeting 5
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: